Skip to main content

Seneca bring VCT offering to the market

Seneca bring VCT offering to the market

Regional SME specialists, Seneca Partners have announced plans to supplement their Tax Advantaged product range with the launch of the Seneca Growth Capital VCT PLC during Quarter 1 of 2018.

The North West based Investment and Corporate Advisory business is seeking to build on the strong success of their EIS investment activities which also invests in the region’s growing companies.

Seneca’s Managing Partner, Richard Manley commented:

“We are long standing Growth Capital investors through our EIS division which has deployed c.£70 million in the region’s brightest prospects over the last 4 years and the addition of our VCT will offer investors a different tax advantaged option in an area of substantial strength for Seneca.

The announcements made in the Budget recently, together with the vitally important Patient Capital Review provide further conviction of the support needed by businesses in our heartlands, a cause we will continue to champion. We will maintain our position as ‘generalist’ investors and key supporters across the Northern Powerhouse which is recognised and valued by our investors from all parts of the UK.”

Seneca is pleased to team up with the Directors of Hygea VCT PLC (“Hygea”). The proposal is for Hygea to issue a new class of shares, whose assets will be managed by Seneca, under a more generalist investment policy than currently applies to its existing share class. Please see for further details.

Contact Us

Online Form

If you have any questions about anything you’ve seen on our website then please get in touch. We are here to help. Normal office hours are weekdays 9.00am to 5.00pm. The office is not open on weekends or bank holidays.
  • Would you like to receive Seneca Partners Newsletter updates?

  • Would you like to receive Seneca Partners Onside Magazine?

  • Would you like to receive Seneca Partners Event Updates?

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.